Compliance Reference

FDA Software Compliance Quick Reference

Essential compliance requirements for pharmaceutical software systems

How to Use This Guide

This quick reference covers essential FDA and EU compliance requirements for pharmaceutical software systems. Use it to evaluate QMS, LIMS, MES, and other GxP software solutions.

21 CFR Part 11 - Electronic Records/Signatures

Foundation for FDA-compliant software systems

Must Have:

Unique user logins with password controls (minimum 8 characters, complexity requirements)

Detailed audit trails capturing who, what, when, why for all changes

Electronic signature manifestations (e.g., "Signed by John Doe on 2025-01-15")

Data backup and recovery procedures with documented testing

System access controls and authority checks (role-based permissions)

Device/location checks for critical operations (optional but recommended)

Red Flags:

Shared logins or generic accounts (automatic disqualification)

Deletable or editable audit trails (critical violation)

No signature meaning statements or manifestations

Audit trail timestamp manipulation possible

EU GMP Annex 11 - Computerized Systems

European regulatory framework for computerized systems

Core Requirements:

Risk-based validation approach (GAMP 5 aligned)

Personnel training records with competency assessments

Change control procedures for all system modifications

Incident management system with root cause analysis

Business continuity plan with documented recovery procedures

Accuracy checks for critical data transfers

Supplier quality management and periodic assessment

Key Differences from FDA 21 CFR Part 11:

Requires "Product Quality Review" of computerized systems
Greater emphasis on risk management throughout lifecycle
Broader supplier assessment and audit requirements
More prescriptive on periodic review frequency

GAMP 5 Categories - Validation Approach

Risk-based approach to software validation effort

Category	System Type	Examples	Validation Needed
Cat 3	Non-configured software	Excel, PDF readers	Basic verification
Cat 4	Configured software	QMS, LIMS, MES	Configuration testing + verification
Cat 5	Custom software	Bespoke systems	Full validation lifecycle

Most pharmaceutical software = Category 4

Expect 3-6 months validation timeline for typical Category 4 systems

ALCOA+ Data Integrity Principles

Global standard for data integrity in pharmaceutical operations

Original ALCOA:

AttributableWho created/modified data? Every action traced to specific user with timestamp

LegibleCan you read it? Data remains readable throughout retention period

ContemporaneousRecorded when it happened? Real-time or near-real-time data capture

OriginalFirst capture, not copy? Original record or certified true copy

AccurateCorrect and complete? No errors, alterations documented

Plus (+) Extensions:

CompleteAll data included? No selective reporting

ConsistentSame across systems? Data integrity maintained across transfers

EnduringAvailable for retention period? Typically 5+ years for GxP data

AvailableAccessible when needed? For review, inspection, audit

Critical Questions for Vendors

Ask these during vendor demonstrations and RFP responses

Validation Support

☑ Do you provide IQ/OQ/PQ protocols?

Look for: Pre-validated templates, included at no cost, regularly updated

☑ Is validation documentation included in license?

Look for: No extra fees, comprehensive package, version control

☑ What's your typical validation timeline?

Look for: Realistic estimates (3-6 months typical), past project data

Technical Compliance

☑ How are audit trails protected from deletion/modification?

Look for: Immutable, encrypted, separate storage from operational data

☑ Can electronic signatures be bypassed?

Look for: No admin override, mandatory for critical actions, two-factor available

☑ What's your data retention and archival capability?

Look for: Minimum 5 years, searchable archive, certified export

Vendor Assessment

☑ Do you allow on-site customer audits?

Look for: Yes with reasonable notice, QA audit reports available

☑ What ISO certifications do you hold?

Look for: ISO 9001 (Quality), ISO 27001 (Security), ISO 13485 (Medical)

☑ Is your disaster recovery plan documented and tested?

Look for: Annual DR testing, RTO/RPO defined, backup verification

Common Compliance Failures

Recurring issues found during FDA/EMA inspections

Excel Spreadsheets for GxP Data

Uncontrolled, no audit trail, easy manipulation. Use validated systems instead.

Hybrid Paper/Electronic Systems

Paper signatures on electronic records create compliance gaps and audit issues.

Local Computer Timestamps

Not synchronized to verified time source. Must use NTP-synchronized server time.

Administrator Override Capabilities

System admins bypassing e-signatures or audit trails. Segregate admin from user roles.

Batch Record Deletions

Deleting groups of records without individual justification. All deletions must be tracked.

Inadequate Change Control

System changes without validation assessment. All changes require impact analysis.

Implementation Timeline Impact

How compliance requirements affect project timelines

Compliance Status	Timeline Impact	Notes
21 CFR Part 11 Ready	Baseline	Out-of-box compliance, validation package included
Needs Configuration	+2-3 months	Workflow setup, testing, documentation
Needs Customization	+4-6 months	Development, testing, revalidation required
Full CSV Validation	+3-4 months minimum	IQ/OQ/PQ execution, added to implementation
Multi-site Deployment	+2-3 months per site	Parallel or sequential rollout strategy

Regulatory Inspection Focus Areas

What inspectors check during facility audits

FDA Loves to Check:

Audit trail reviews - completeness, no gaps, proper reasons for change
User access management - terminated employees, role appropriateness
Change control records - validation assessment for all changes
Training documentation - competency assessments, currency
Backup/recovery testing - frequency, restoration success rate
Data integrity controls - ALCOA+ principles implementation

EMA Emphasizes:

Risk assessments - documentation of risk-based decisions
Supplier qualification - vendor audits, quality agreements
Data integrity controls - electronic vs paper record consistency
Backup/recovery testing - documented test results, RTO achievement
Periodic review execution - annual system reviews performed
Business continuity plans - tested, documented, staff trained

Pro Tip:

Keep "inspection-ready" documentation packages. Inspectors typically request: validation summary report, audit trail samples, user access matrix, change control log (last 12 months), backup/recovery test results.

Find Compliant Software Solutions

Browse pharmaceutical software vendors that support FDA 21 CFR Part 11, GAMP 5, and GxP compliance requirements.

Quality Management Systems (QMS)

CAPA, document control, deviation management with 21 CFR Part 11 compliance

Laboratory Information Systems (LIMS)

Sample tracking, OOS investigations, CoA generation with ALCOA+ data integrity

Manufacturing Execution Systems (MES)

Electronic batch records, real-time monitoring, equipment integration

Validation & CSV Software

IQ/OQ/PQ protocols, GAMP 5 aligned validation documentation

Last updated: January 2025 | This is a general reference guide. Always consult current regulations and your quality team for specific requirements.

Remember: No software is "validated" out-of-the-box - validation is specific to your intended use and system configuration.